All In Biotech

Free tool

FAERS Monitor: Korsuva

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214916 or its brand name (Korsuva, Difelikefalin Acetate). Reports on generic versions are filed under their own applications.

Reports

413

Serious

297

72% of reports

Hospitalization

124

Death reported

64

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dizziness45
  • somnolence40
  • fall35
  • death30
  • drug ineffective24
  • mental status changes23
  • confusional state19
  • asthenia18
  • nausea18
  • off label use17
  • pruritus17
  • hallucination16
  • blood pressure decreased14
  • drug reaction with eosinophilia and systemic symptoms14
  • altered state of consciousness11

Reports by year received

View as table
YearReports
202261
2023124
202483
2025102
202643

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,746 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
mental status changesSignal2342.228.4885
drug reaction with eosinophilia and systemic symptomsSignal1427.716.6335
altered state of consciousnessSignal1125.914.4239
hallucinationSignal1610.86.7133
blood pressure decreasedSignal1410.76.4114
somnolenceSignal4010.17.5323
confusional stateSignal196.03.975
fallSignal355.43.9122
dizzinessSignal454.63.5126
astheniaSignal182.41.614
pruritusSignal172.31.411
death301.81.310
nausea181.20.70
off label use171.00.60
drug ineffective240.90.60

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.